Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating
Wedbush 将一代生物股价目标价从9美元调整至5美元,维持跑赢大盘评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册